Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.
- NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_assertion description "[ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin II receptor blockers) are already widely used for the treatment and prevention of cardiovascular disease and their potential role in other disease states has become increasingly recognized.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.
- NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_assertion evidence source_evidence_literature NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.
- NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_assertion SIO_000772 22757959 NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.
- NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_assertion wasDerivedFrom befree-20140225 NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.
- NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_assertion wasGeneratedBy ECO_0000203 NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.
- befree-20140225 importedOn "2014-02-25" NP422915.RA4dj6iJCnGoQ1UoeB9JepdF7pp05HlMoBjdYFVqX8_4A130_provenance.